Skip to main content
. 2022 May 24;23(11):5892. doi: 10.3390/ijms23115892

Figure 4.

Figure 4

Determination of relative cancer cell viability of pancreas adenocarcinoma cell line (BxPC-3), colorectal carcinoma cell line (HCT-116) and prostate adenocarcinoma cell line (PC-3) treated with MM-compounds; ±SEM.